AstraZeneca Expands Cancer Work With €62.6M Innate Stake - McDermott Will & Emery

AstraZeneca Expands Cancer Work With €62.6M Innate Stake

Overview


Emmanuelle Trombe, Anne-France Moreau, Richard Smith, Gary Howes Antonina Nijran, Antoine Vergnat, Romain Desmonts, Côme de Saint Vincent, and Christine Wahrin represented Innate Pharma, an oncology-focused biotech company, in expanding their cooperation with AstraZeneca, a pharmaceutical and biopharmaceutical company.